The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.

Zygolide ® is a first-to-market generic, peppermint-flavored pergolide tablet, offering enhanced features for horses ...

The company was seeking approval for relacorilant as a treatment for patients with hypertension secondary to hypercortisolism ...

Jesy Nelson noticed worrying signs about her twin daughters’ Ocean Jade and Story Monroe’s health, weeks before they were ...

The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...

“Sometimes, a little bit of facial hair, specifically chin hair, can be normal,” said Dr. Divya Sistla, an endocrinologist at ...

The first-to-market generic, peppermint-flavored pergolide tablet offers enhanced features for horses suffering from PPID.

Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter ("CRL" ...

Amy Schumer's used liposuction and medications like Wegovy and Mounjaro to lose weight over the last few years, and her ...

Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year.

Half a century ago, Peter Jensen launched Project Censored, in part as a response to how the Watergate break-in was covered.

Heart disease is one of the leading causes of death across the world. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) caused almost 19.8 million deaths in 2022, which ...